Canada's MEDEC recommends industry-wide adoption of revised code of conduct
This article was originally published in RAJ Devices
Canada’s medical technology industry association MEDEC has “revised and restated” its 2005 code of conduct for companies on their interactions with healthcare professionals. The group is urging all medtech companies in Canada – not just MEDEC members – to adopt the updated code and to implement an effective compliance programme.
You may also be interested in...
Amgen had a good third quarter despite some COVID-19 impacts but did not shed any light on filing plans for two key late-stage programs nor provide any insight into Phase III asthma results for tezepelumab.
The company is narrowing its 2020 guidance, citing COVID-19’s unpredictability and its effects on Veklury’s sales.
The price of the antibody monotherapy for COVID-19 will be $1,250 per vial for wealthy countries. CEO David Ricks outlined the company's guidelines for pricing and distributing a limited supply.